Literature DB >> 3345538

Lack of suppressive activity of human primary melanoma cells on the activation of autologous lymphocytes.

D Taramelli1, A Mazzocchi, C Clemente, G Fossati, G Parmiani.   

Abstract

Previous studies have indicated that primary but not metastatic melanomas were able to stimulate the proliferation of autologous (Auto) peripheral blood lymphocytes (PBL) in 73% of cases. On the other hand, 57% of the metastatic melanomas were shown to be suppressive when melanoma cells (Me) were admixed with Auto-PBL stimulated with allogeneic (Allo) PBL or interleukin 2 (IL-2) at the beginning of a 6-day incubation period. Here, we report that the suppressive activity of Me is a functional characteristic associated with a particular stage of the disease. In fact, we found that none of the 11 primary tumors tested were able to inhibit the proliferative response of Auto-PBL to Allo-PBL or IL-2 at all the doses of tumor cells used. The generation of lymphocytes cytotoxic against Auto-Me or K562 was also not inhibited. Of the 11 primary tumors checked for suppression, 8 were able to stimulate Auto-PBL in a primary mixed lymphocyte tumor culture. We conclude that opposite functions, stimulation and inhibition of autologous lymphocyte responses are characteristics of primary and metastatic Me, respectively.

Entities:  

Mesh:

Year:  1988        PMID: 3345538     DOI: 10.1007/bf00199849

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  24 in total

1.  Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours.

Authors:  B M Vose; M Moore
Journal:  Int J Cancer       Date:  1979-11-15       Impact factor: 7.396

Review 2.  Immune response to autologous human melanoma: implication of class I and II MHC products.

Authors:  G Fossati; A Anichini; D Taramelli; A Balsari; C Gambacorti-Passerini; J M Kirkwood; G Parmiani
Journal:  Biochim Biophys Acta       Date:  1986-12-17

3.  Distinct forms of both alpha and beta subunits are present in the human Ia molecular pool.

Authors:  R S Accolla; N Gross; S Carrel; G Corte
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

4.  Enhancement of production of superoxide anion by human monocytes exposed to products of HT 29 human colonic adenocarcinoma cell line.

Authors:  D Bettetini; F Garrouste; M Remacle-Bonnet; J M Culouscou; J Marvaldi; G Pommier
Journal:  Int J Cancer       Date:  1987-02-15       Impact factor: 7.396

Review 5.  Activation of lymphocyte anti-tumour responses in man: effector heterogeneity and the search for immunomodulators.

Authors:  B M Vose
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

6.  Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression.

Authors:  B Mukherji; A L Nashed; A Guha; M T Ergin
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

7.  Phenotypic dynamics of tumor progression in human malignant melanoma.

Authors:  E B Bröcker; L Suter; J Brüggen; D J Ruiter; E Macher; C Sorg
Journal:  Int J Cancer       Date:  1985-07-15       Impact factor: 7.396

8.  Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytes.

Authors:  G Fossati; A Balsari; D Taramelli; M L Sensi; G Pellegris; M Nava; G Parmiani
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

9.  The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA-DR antigens on the tumor cells.

Authors:  D Taramelli; G Fossati; A Balsari; R Marolda; G Parmiani
Journal:  Int J Cancer       Date:  1984-12-15       Impact factor: 7.396

10.  Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies.

Authors:  B S Wilson; K Imai; P G Natali; S Ferrone
Journal:  Int J Cancer       Date:  1981-09-15       Impact factor: 7.396

View more
  2 in total

1.  T lymphocytes can mediate lysis of autologous melanoma cells by multiple mechanisms: evidence with a single T cell clone.

Authors:  A Mazzocchi; A Anichini; C Castelli; M Sensi; F Poli; C Russo; G Parmiani
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.

Authors:  B Mukherji; A Guha; N G Chakraborty; M Sivanandham; A L Nashed; J R Sporn; M T Ergin
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.